I’m running this marathon to win it. I want to say don’t let a wall stop you; keep running, keep fighting!
Dr. Inga Hofman Zhang from the University of Wisconsin School of Medicine provides an update on treating MDS in children.
Jean LaMantia was only 27 years old when she was diagnosed with Hodgkin lymphoma. Since then, she has completely overhauled her diet to focus on the nutrients best suited for cancer prevention.
Physician Uri Goldberg discusses an observational cross-sectional study that catalogued depression among patients with cancer by stage and source of malignancy.
An essay from our Extraordinary Healers book honoring Terry Hoelz, RN, OCN [Ridgeview Medical Center in Waconia, Minnesota]
Finalist for the 2015 Extraordinary Healer Award for Oncology Nursing: Elmeria S. Teffeteller, RN, MSN, APRN, AOCN, University of Tennessee Cancer Institute in Knoxville, Tennessee
Fighting colon cancer was only part of the battle; this survivor then had to learn how, and what, to eat all over again.
George Valentine needs something from his elected representatives in Congress: securing predictable annual out-of-pocket costs under Medicare Part D’s prescription drug plan.
Madeleine Henriquez noticed that the mental health care of patients with MPN was being overlooked and took action in a way that has changed her community for the better.
Jill Stopfer, from the University of Pennsylvania, provides an overview of some limitations of multigene panel testing.
A family collaborated on this essay to nominate registered oncology nurse Susan DeVictor for CURE®’s 2019 Extraordinary Healer® Award.
Association of Community Cancer Centers' survey finds heavy workloads and workflow inefficiencies are top concerns.
Finalist essay for CURE's 2012 Extraordinary Healer Award for Oncology Nursing.
Providers spend a great deal of their time treating cancer, but how much time is being spent treating the patient?
A cancer diagnosis can sometimes stop a friendship in its tracks.
When I was diagnosed with Hodgkin's lymphoma, I envisioned myself in a galaxy far, far away. Just like any well-trained Jedi, I fought back when insurance denied my claim for doctor-recommended treatment.
PARP inhibitors are generating a lot of excitement in the field of ovarian cancer. But how, exactly, do they work? CURE spoke with one expert to find out.
People experiencing gastrointestinal symptoms or delays in colorectal cancer care should address these questions with their care team.
An Extraordinary Healer essay honoring MARJORIE CASTO THEILIG, RN-BC, B.S.N. [MD ANDERSON CANCER CENTER AT COOPER, VOORHEES TOWNSHIP, NEW JERSEY]
Ishwaria Mohan Subbiah, a physician at the MD Anderson Cancer Center, discusses elderly people on clinical trials.
As cancer survivors are living longer thanks to new treatments, it is essential that health care providers and researchers put more focus on depression.
In the analysis, there was as much as a 92 percent difference in median overall survival (OS) seen between patients treated in randomized controlled trials and "real world" data.
We are all healers of the world no matter who we are. We are here because we can make a difference.
Creams containing the chemotherapy 5-fluorouracil can be fatal to animals, the FDA warns.
Clinical trials offer a chance to try experimental treatments and move the state of science forward. Here’s what patients need to know.
“Survivor: Africa” winner Ethan Zohn details his journey with cancer and discovering that it isn’t a sprint, but a marathon.
There are three things that should be considered when deciding what is the optimal treatment in the first line setting for patients with chronic lymphocytic leukemia (CLL), according to Dr. Mazyar Shadman.